NCT06627348 (HiPPo) is a NA clinical trial of Hilotherm ChemoCare in Equipment and Supplies, sponsored by University of Ulm.

Who is sponsoring NCT06627348?

NCT06627348 is sponsored by University of Ulm.

What drugs are being tested in NCT06627348?

Interventions in NCT06627348: Hilotherm ChemoCare.

What condition does NCT06627348 study?

NCT06627348 studies Equipment and Supplies.

Is NCT06627348 still recruiting?

NCT06627348 is currently recruiting now. Last updated 4 October 2024.

Last reviewed 2024-10-04 · How we verify

NCT06627348: HiPPo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy

Recruiting now NA Last updated 4 October 2024

What this trial tests

NA trial testing Hilotherm ChemoCare in Equipment and Supplies in 150 participants. Currently enrolling.

Timeline

17 April 2024

Primary endpoint
31 March 2027

31 March 2027

Quick facts

Lead sponsor	University of Ulm
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	150
Start date	17 April 2024
Primary completion	31 March 2027
Estimated completion	31 March 2027
Sites	1 location across Germany

Drugs / interventions tested

Hilotherm ChemoCare

Conditions studied

Equipment and Supplies — all drugs for Equipment and Supplies →

Sponsor

University of Ulm

Who can join

18 and older, female only, with Equipment and Supplies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective study of hilotherapy of hands and feet as prevention of chemotherapy-induced peripheral polyneuropathy induced by Taxan-based chemotherapy regimen that are used in the therapy of breast cancer and genital malignoma of the women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Equipment and Supplies

Currently open trials in the same condition.

NCT05849753 — Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes · recruiting

Other University of Ulm trials

Trials by the same sponsor.

NCT07436195 — Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA · recruiting
NCT07154524 — Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) · recruiting
NCT06877143 — Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis · NA · recruiting
NCT06280079 — Ultra-high-caloric, Fatty Diet in ALS · NA · recruiting
NCT06170905 — Whey Protein Pre-load and Postprandial Glycemia in Pregnancy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06627348 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Ulm
Last refreshed: 4 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06627348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing